Our results showed that PODXL knockdown significantly increased cell apoptosis in the presence of temozolamide, suggesting that PODXL may be a potential target for overcoming chemoresistance in astrocytomas, particularly, glioblastomas. The gene discussed is PODXL; the disease is astrocytoma (excluding glioblastoma).